Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease

Hyperuricemia is a frequent complication of chronic kidney disease (CKD). Febuxostat is a novel xanthine oxidase inhibitor that is metabolized by many metabolic pathways in the kidney and the liver. We performed a 1-year cohort study of 73 hyperuricemic patients who had an estimated glomerular filtr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruta, Yuki, Mochizuki, Toshio, Moriyama, Takahito, Itabashi, Mitsuyo, Takei, Takashi, Tsuchiya, Ken, Nitta, Kosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192559/
https://www.ncbi.nlm.nih.gov/pubmed/25048744
http://dx.doi.org/10.1007/s10067-014-2745-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192559/
https://www.ncbi.nlm.nih.gov/pubmed/25048744
http://dx.doi.org/10.1007/s10067-014-2745-5

Ejemplares similares